- Founded: 2013
- CEO: Chad Rogers
- Size of Facility: 2500 sq ft
- Company Size: 15
- Funding Source: Grants (e.g. SBIR, CRCF, CIT), Investor Funded, Venture Captital/Private Equity
- Development Stage: Not Applicable
TypeZero develops diabetes management technologies using advanced predictive algorithms coupled with artificial intelligence to produce personalized, contextually aware treatments and tools for patients with Type 1 and Type 2 diabetes.